• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchPolaryx Therapeutics
    Picture of Polaryx Therapeutics logo

    PLYX — Polaryx Therapeutics News Story

    $1.850.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    • Market Cap
      $92.22m
    • Enterprise Value
      $80.67m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • PLYX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    PLYX Dividends
    All News

    NASDAQ RESUMED AT 09:57 AM

    Picture of Polaryx Therapeutics logoPolaryx Therapeutics
    04/02/2026 14:57
    NASDAQ RESUMED  PLYX.O  AT 09:57 AM
    

    Recent news on Polaryx Therapeutics

    See all news
    • Brief: Polaryx Therapeutics Closes $10 Million Private Placement Equity Financing

      28/05/2026 13:37
    • U.S. STOCKS ON THE MOVE-Northern Trust, UnitedHealth, Tractor Supply

      21/04/2026 18:58
    • U.S. STOCKS ON THE MOVE-Intel, Teradyne, MSCI

      21/04/2026 16:49
    • Polaryx rises after FDA grants fast-track status for rare disease drug

      21/04/2026 14:11
    • Brief: Polaryx Therapeutics Receives U.S. FDA Fast Track Designations For All Four Indications To Be Evaluated In The Soteria Basket Trial

      21/04/2026 13:48

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.